Sheila Jacobs

A study was conducted to determine risk for ischemic heart disease in patients that have history of tuberculosis.

A study was conducted to determine the effect of SARS-CoV-2 infection on vascular health in children.

Researchers characterized the clinical severity and frequency of RSV infection among hospitalized adults over 3 seasons of acute respiratory illness.

Researchers studied outcomes of pregnant and postpartum patients admitted to the ICU for severe COVID-19 pneumonitis from week 13 of gestation to 1 week postpartum.

Researchers identified the risk factors and underlying etiologies for hyponatremia in patients with acute exacerbation of COPD.

Researchers compared the sensitivity and specificity of 2 frailty screening tools — the Hospital Frailty Risk Score and the Clinical Frailty Scale — in patients with COPD.

Researchers examined associations between air pollution and the progression of chronic lung diseases toward lung multimorbidity and mortality.

Investigators established impulse oscillometry-based measures for evaluating small airway function in adults with asthma.

In a randomized clinical trial, researchers established whether intranasal mometasone furoate is more effective than intranasal saline for the improvement of symptoms and quality of life in children with sleep-disordered breathing.

A clinical trial compared a restrictive vs liberal fluid strategy for patients with sepsis-induced hypotension refractory to initial treatment with IV fluid.

Researchers sought to evaluate the risk for incident myocarditis within 1 year following infection with COVID-19.

A clinical trial compared outcomes associated with 2 approaches to extubation used in ICUs: continued enteral nutrition until extubation vs fasting prior to extubation.

Researchers sought to investigate seizure outcomes following SARS-CoV-2 mRNA vaccination in people with epilepsy.

Researchers explored the links between latent TB infection status, host immunity, and gut microbiota dybiosis in patients with poorly controlled diabetes.

Researchers explored whether short-term probiotic supplementation in patients with asthma can improve asthma symptoms, miRNA expression, and IL-4 and IFN-γ levels.

In patients receiving pulmonary rehabilitation for COPD, can functional brain imaging markers of breathlessness-expectation predict of rehabilitation responses?

A secondary analysis of the REMAP-CAP trial evaluated long-term outcomes of multiple interventions used for critically ill patients with COVID-19.

How does an artificial intelligence model for detecting the presence of nontension and tension pneumothorax compare with a radiologist consensus model?

A clinical trial in China evaluated a pediatric PAH risk assessment tool, while using that tool to describe PPAH characteristics and long-term survival in a developing country.

How do rates of hospitalization and death in those 60 and older compare for RSV and influenza? A meta-analysis explored this question.

A post hoc analysis of the ASPECT-NP trial analyzed ceftolozane/tazobactam vs meropenem for treatment-refractory bacterial pneumonia.

A post hoc analysis the ETHOS trial assessed how baseline EOS affected the treatment benefits of BGF triple therapy over dual therapy in patients with COPD exacerbations.

Investigators assessed the prevalence of sleep apnea among patients 3 months after an ICU stay for COVID-19 pneumonia.

How did relaxation of pandemic-related restrictions affect asthma exacerbations, and what does this show about the association between asthma, COVID-19, and other ARIs?

How well does a positive anti-Mycobacterium avium complex antibody test predict a diagnosis of nontuberculous mycobacterial pulmonary disease?

A Maryland study identified patterns of RSV and HPIV-3 in children aged 0 to 4 years later in the pandemic, from November 2020 to March 2021.

How did the COVID-19 pandemic affect the care of patients with pulmonary hypertension? A provider survey explored this question.

In a secondary analysis of the PROFILE trial of IPF, researches used machine learning to identify distinct clusters of lung function trajectory among individuals with IPF.

The SIMPLIFY clinical trial examined ways to alleviate the considerable treatment burden experienced by individuals with cystic fibrosis.

Can low FEF25-75 be used to identify individuals with a history of smoking who may have airflow limitation and who may need early intervention for COPD?